AAAAAA

   
Results: 1-9 |
Results: 9
The role of the urokinase-type plasminogen activator (uPA) and its receptor (CD87) in lipodermatosclerosis
Authors: Herouy, Y Aizpurua, J Stetter, C Dichmann, S Idzko, M Hofmann, C Gitsch, G Vanscheidt, W Schopf, E Norgauer, J
Citation: Y. Herouy et al., The role of the urokinase-type plasminogen activator (uPA) and its receptor (CD87) in lipodermatosclerosis, J CUT PATH, 28(6), 2001, pp. 291-297
Immunohistochemical detection of lymph node metastases in node-negative breast cancer patients
Authors: Kohlberger, P Gantert, M Volk-Orlowska, T Kieback, DG Gitsch, G
Citation: P. Kohlberger et al., Immunohistochemical detection of lymph node metastases in node-negative breast cancer patients, ANTICANC R, 21(1B), 2001, pp. 697-699
Breast size as risk factor for tumor size at diagnosis
Authors: Hasenburg, A Grothey, A Jaspers, V Gitsch, G Spatling, L
Citation: A. Hasenburg et al., Breast size as risk factor for tumor size at diagnosis, ANTICANC R, 20(3B), 2000, pp. 2041-2044
Comparison of flow cytometry and RT-PCR for the detection of ovarian cancer cells in peripheral blood
Authors: Stimpfl, M Schmid, BC Obermair, A Tong, D Schiebel, I Gitsch, G Leodolter, S Zeillinger, R
Citation: M. Stimpfl et al., Comparison of flow cytometry and RT-PCR for the detection of ovarian cancer cells in peripheral blood, ONCOL RES, 11(8), 1999, pp. 367-373
Prognostic significance of tumor angiogenesis in primary fallopian tube cancer
Authors: Bancher-Todesca, D Rosen, A Graf, A Wasicky, R Hohlagschwandtner, M Rebhandl, W Heinze, G Breitenecker, G Gitsch, G Obermair, A
Citation: D. Bancher-todesca et al., Prognostic significance of tumor angiogenesis in primary fallopian tube cancer, CANCER LETT, 141(1-2), 1999, pp. 179-186
Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage IB cervical cancer
Authors: Moser, PL Kieback, DG Hefler, L Tempfer, C Neunteufel, W Gitsch, G
Citation: Pl. Moser et al., Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage IB cervical cancer, ANTICANC R, 19(5C), 1999, pp. 4391-4393
Modified true-color computer-assisted image analysis versus subjective scoring of estrogen receptor expression in breast cancer: A comparison
Authors: Kohlberger, PD Breitenecker, F Kaider, A Losch, A Gitsch, G Breitenecker, G Kieback, DG
Citation: Pd. Kohlberger et al., Modified true-color computer-assisted image analysis versus subjective scoring of estrogen receptor expression in breast cancer: A comparison, ANTICANC R, 19(3B), 1999, pp. 2189-2193
Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer
Authors: Moser, PL Hefler, L Tempfer, C Neunteufel, W Kieback, DG Gitsch, G
Citation: Pl. Moser et al., Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer, ANTICANC R, 19(3B), 1999, pp. 2365-2367
Comparative evaluation of seven cell collection devices for cervical smears
Authors: Kohlberger, PD Stani, J Gitsch, G Kieback, DG Breitenecker, G
Citation: Pd. Kohlberger et al., Comparative evaluation of seven cell collection devices for cervical smears, ACT CYTOL, 43(6), 1999, pp. 1023-1026
Risultati: 1-9 |